β-聚葡萄糖产品市场：依原料、等级及地区划分

2026 年 β-聚葡萄糖产品的市场规模估计为 7.1 亿美元，预计到 2033 年将达到 12.5 亿美元，2026 年至 2033 年的年复合成长率（CAGR）为 9.8%。

β-聚葡萄糖是膳食纤维的重要组成部分，可从燕麦、大麦、细菌和酵母中提取。它具有多种生理作用，包括降低血浆胆固醇水平、调节餐后血糖值和免疫调节作用。除了食品工业外，β-聚葡萄糖在製药、医疗、化妆品和工业领域以及最终产品製造的应用也日益广泛。

β-聚葡萄糖具有调节免疫系统和降低血糖值的作用，因此可能成为治疗糖尿病的潜在药物。它们还能透过降低胆固醇水平来预防心臟病发作，并具有抗肿瘤作用。在医学上，β-聚葡萄糖被用于治疗多种疾病，包括高胆固醇症、糖尿病、癌症和爱滋病。

市场动态

β-葡聚醣作为一种潜在活性成分，在食品、医疗、製药、动物饲料和工业等领域的应用日益广泛，预计将导致对β-葡聚醣的需求增加，从而在不久的将来推动市场成长。此外，β-葡聚醣的健康益处，以及全球消费者对营养食品和膳食补充剂的偏好不断变化，预计也将推动市场成长。

此外，主要市场参与者正致力于采取各种策略来获取更大的市场份额，这也有望促进市场成长。例如，2017年4月，凯敏工业公司（Kemin Industries）从总部位于美国普利茅斯的Algal Scientific公司收购了β-葡聚醣生产技术。此外，2014年10月，Nutra-Q公司宣布与美国国际化学公司（AIC）建立销售合作伙伴关係，由AIC在美国、加拿大和墨西哥独家销售NBG系列β-葡聚醣产品。

本次调查的主要特点

• 本报告对β-聚葡萄糖产品市场进行了详细分析，以2025年为基准年，给出了预测期（2026-2033年）内的市场规模和复合年增长率（%）。
• 它还重点介绍了各个细分市场的潜在商机，并说明了该市场具有吸引力的投资提案矩阵。
• 该研究还提供了有关脊椎管理产品的市场驱动因素、限制因素、机会、核准和上市、区域前景以及主要企业采取的竞争策略的重要见解。
• 该报告根据以下参数对全球β-聚葡萄糖产品市场的主要企业进行了分析：公司概况、财务业绩、产品系列、地理扩张、分销策略、关键发展和策略以及未来计划。
• 本报告的研究结果将有助于负责人和企业经营团队就即将推出的产品、製造设施升级、市场扩张和行销策略做出明智的决策。
• 这份全球β-聚葡萄糖产品市场报告针对产业内的各种相关人员，包括投资者、供应商、β-聚葡萄糖产品製造商、经销商、新参与企业和金融分析师。
• 相关人员将能够透过用于分析β-聚葡萄糖产品市场的各种策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

• 调查目的
• 先决条件
• 简称

第二章 市场概览

• 报告概述
  • 市场定义和范围
• 执行摘要

第三章 市场动态、监理及趋势分析

• 市场动态
• 影响分析
• 主要亮点
• 法规环境
• 产品上市及核准情况
• PEST分析
• 波特分析
• 市场机会
• 法规环境
• 重大进展
• 产业趋势

4. 2026-2033年全球β-聚葡萄糖产品市场（依来源划分）

• 粮食
• 酵母菌
• 菇
• 其他的

5. 2026-2033年全球β-聚葡萄糖产品市场（依等级划分）

• 製药
• 医疗保健
• 食物
• 化妆品
• 提高石油采收率（EOR）
• 动物饲料

6. 2026-2033年全球β-聚葡萄糖产品市场（按地区划分）

• 北美洲
  • 我们
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲国家
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 亚太其他地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东国家
• 非洲
  • 南非
  • 北非
  • 中非

第七章 竞争情势

• Jkosmmune
• Lesaffre Group
• Garuda International, Inc.
• Ohly GmBH
• Koninklijke DSM NV
• Kerry Group PLC
• STR Biotech Co. Ltd.
• Macrocare Tech Co., Ltd.
• Amarte USA, LLC
• Ceapro Inc.
• Biotec Pharmacon ASA
• Quegen Biotech Co., Ltd.
• Kemin Industries, Inc.
• NutraQ AS
• Lantmannen
• Carbon Medical Technologies, Inc.
• Givaudan SA
• Danaher Corporation
• Super Beta Glucan Inc.
• AIPPO

第八章 分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第九章 参考文献与调查方法

• 参考
• 调查方法
• 关于本公司

Beta Glucan Based Products Market is estimated to be valued at USD 710 Mn in 2026 and is expected to reach USD 1,250 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.8% from 2026 to 2033.

Beta glucan is an important component of dietary fiber, which can be extracted from oat, barley, bacteria, and yeast. It possesses several physiological effects, including lowering plasma cholesterol level, control of postprandial glucose level, and immune modulation effects. Apart from the food industry, beta glucan is increasingly being used in the pharmaceutical, medical, cosmetic, and industrial applications, and end product manufacturing.

Beta glucans can act as an immune system modulator and also has the ability to reduce blood glucose, and it may be used in the treatment of diabetes mellitus. Beta glucans can protect the body from heart attack by lowering cholesterol levels and it also acts as an anti-tumor agent. Beta glucans are used in medical field to treat various diseases including hyper cholesterolemia, diabetes, cancer, and HIV/AIDS.

Market Dynamics

Increasing applications of beta glucan as potential active ingredient in various food, medical, pharmaceutical, animal feed, and industrial applications is expected to increase demand for beta glucan and this is expected to aid in growth of the market in the near future. Moreover, health benefits of beta glucan along with changing consumer preferences towards use of nutritious food and dietary supplements among global population is expected to propel the market growth.

Furthermore, key players in the market are focusing on gaining significant market share by adopting various strategies and this is expected to aid in the market growth. For instance, in April 2017, Kemin Industries acquired a beta-glucan manufacturing technology from Algal Scientific, a company headquartered in Plymouth, U.S. In October 2014, NutraQ announced that it entered into a distribution partnership with American International Chemical LLC (AIC) to exclusively distribute NBG range of beta-glucans in in the U.S., Canada, and Mexico.

Key features of the study

• This report provides in-depth analysis of beta glucan based products market and provides market size (USD Mn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 - 2033), considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains an attractive investment proposition matrix for this market
• This study also provides key insights into market drivers, restraints, opportunities, scoliosis management product approval & launch, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global beta glucan based products market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as part of this study include Jkosmmune, Lesaffre Group, Merck KGaA, Garuda International, Inc., Ohly GmBH, Koninklijke DSM N.V., Kerry Group PLC, STR Biotech Co. Ltd., Macrocare Tech Co., Ltd., Amarte USA, LLC, Ceapro Inc., Biotec Pharmacon ASA, Quegen Biotech Co., Ltd., Kemin Industries, Inc., NutraQ AS, Lantmannen, Carbon Medical Technologies, Inc., Givaudan SA, Danaher Corporation, Super Beta Glucan Inc., and AIPPO
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, manufacturing up-gradation, market expansion, and marketing tactics
• The global beta glucan based products market report caters to various stakeholders in this industry including investors, suppliers, beta glucan based product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the beta glucan based products market

Market Segmentation

• Source Insights (Revenue, USD Mn, 2026 - 2033)
  • Cereals
  • Yeast
  • Mushroom
  • Others
• Grade Insights (Revenue, USD Mn, 2026 - 2033)
  • Pharma
  • Medical
  • Food
  • Cosmetics
  • Enhanced Oil Recovery
  • Animal Feed
• Regional Insights (Revenue, USD Mn, 2026 - 2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • North Africa
  • Central Africa
  • South Africa
• Key Players Insights
  • Jkosmmune
  • Lesaffre Group
  • Garuda International, Inc.
  • Ohly GmbH
  • Koninklijke DSM N.V.
  • Kerry Group PLC
  • STR Biotech Co. Ltd.
  • Macrocare Tech Co., Ltd.
  • Amarte USA, LLC
  • Ceapro Inc.
  • Biotec Pharmacon ASA
  • Quegen Biotech Co., Ltd.
  • Kemin Industries, Inc.
  • NutraQ AS
  • Lantmannen
  • Carbon Medical Technologies, Inc.
  • Givaudan SA
  • Danaher Corporation
  • Super Beta Glucan Inc.
  • AIPPO

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Beta Glucan Based Products Market, By Source
  • Global Beta Glucan Based Products Market, By Grade
  • Global Beta Glucan Based Products Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Market Opportunities
• Regulatory Scenario
• Key Developments
• Industry Trend

4. Global Beta Glucan Based Products Market, By Source, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Cereals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Yeast
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Mushroom
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global Beta Glucan Based Products Market, By Grade, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Pharma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Medical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Food
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Cosmetics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Enhanced Oil Recovery (EOR)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Animal Feed
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global Beta Glucan Based Products Market, By Region, 2026 - 2033, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Source, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Grade, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Source, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Grade, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Source, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Grade, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Source, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Grade, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Source, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Grade, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Source, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Grade, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

7. Competitive Landscape

• Jkosmmune
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lesaffre Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Garuda International, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ohly GmBH
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Koninklijke DSM N.V.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Kerry Group PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• STR Biotech Co. Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Macrocare Tech Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Amarte USA, LLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ceapro Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Biotec Pharmacon ASA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Quegen Biotech Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Kemin Industries, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• NutraQ AS
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lantmannen
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Carbon Medical Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Givaudan SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Danaher Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Super Beta Glucan Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AIPPO
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

8. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

9. References and Research Methodology

• References
• Research Methodology
• About us